(See also Overview of Prion Diseases Overview of Prion Diseases Prion diseases are progressive, fatal, and untreatable degenerative brain disorders. Prominent types of prion diseases include Creutzfeldt-Jakob disease (CJD), the prototypic example (usually... read more .)
Variably protease-sensitive prionopathy occurs in 1 to 2/100 million people.
VPSPr resembles Gerstmann-Sträussler-Scheinker disease Gerstmann-Sträussler-Scheinker Disease (GSS) Gerstmann-Sträussler-Scheinker disease is an autosomal dominant prion brain disease that typically begins during middle age. (See also Overview of Prion Diseases.) Gerstmann-Sträussler-Scheinker... read more (GSS) in terms of the characteristics of the abnormal prion protein (PrPSc). However, unlike in GSS, no mutations in the prion protein gene have been identified.
Clinical manifestations differ from those of Creutzfeldt-Jakob disease Creutzfeldt-Jakob Disease (CJD) Creutzfeldt-Jakob disease (CJD) is the most common human prion disease. It occurs worldwide and has several forms and subtypes. CJD symptoms include dementia, myoclonus, and other central nervous... read more , and the PrPSc is less resistant to digestion by proteases; some variants are more sensitive to proteases than others, hence the name: variably protease-sensitive.
Patients present with psychiatric symptoms, speech deficits (aphasia and/or dysarthria), and cognitive impairment. Ataxia and parkinsonism can develop. Average age at onset is 70 years, and duration of survival is 24 months. About 40% of patients have a family history of dementia.
Diagnosis of variably protease-sensitive prionopathy is difficult. MRI, EEG, and tests for 14-3-3 protein and tau are usually not helpful, and no mutations have been observed in the coding region of the PRNP gene.
There is only supportive treatment for VPSPr.